Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial
Titel:
Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial
Auteur:
Blohmer, J.-U. Schmid, P. Hilfrich, J. Friese, K. Kleine-Tebbe, A. Koelbl, H. Sommer, H. Morack, G. Wischnewsky, M.B. Lichtenegger, W. Kuemmel, S.